Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Das Non-Hodgkin-Lymphom ist eine maligne Bluterkrankung mit besonderer Proliperation lymphatischen Gewebes. Bei einigen Erkrankungen finden sich ursachliche Mutationen des CASP10-Gens.
| 1. |
Clementi R et al. (2005) A proportion of patients with lymphoma may harbor mutations of the perforin gene. 
|
| 2. |
Compagno M et al. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
|
| 3. |
Morin RD et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
|
| 4. |
Wiernik PH et al. (2000) Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.
|
| 5. |
Altieri A et al. (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
|
| 6. |
Lenz G et al. (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
|
| 7. |
Davis RE et al. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
|
| 8. |
Morin RD et al. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.
|
| 9. |
Pasqualucci L et al. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
|
| 10. |
Scuoppo C et al. (2012) A tumour suppressor network relying on the polyamine-hypusine axis.
|
 |
Copyright © 2005-2024 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944 Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz | Impressum |
